Reaction
Zygomycosis reporting signals
As of the last recalculation, Zygomycosis appears in 468 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE (PRR 126.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Voriconazole | 73 | 126.4 | 126.8 |
| Voriconazole Injection | 51 | 117.1 | 117.4 |
| Amphotericin B | 27 | 101.6 | 101.9 |
| Posaconazole Delayed-Release | 17 | 71.4 | 71.5 |
| Daspone | 14 | 65.9 | 66.0 |
| Dapsone Gel, 5% | 14 | 65.8 | 65.9 |
| Posaconazole | 22 | 63.1 | 63.2 |
| Pegaspargase | 16 | 60.1 | 60.2 |
| Dapsone | 14 | 60.1 | 60.2 |
| Micafungin Sodium | 11 | 59.1 | 59.1 |
| Itraconazole | 15 | 59.0 | 59.1 |
| Cytarabine | 49 | 40.4 | 40.4 |
| Anti-Thymocyte Globulin (Rabbit) | 7 | 39.2 | 39.2 |
| Vincristine Sulfate | 22 | 35.0 | 35.0 |
| Sirolimus | 9 | 30.3 | 30.3 |
| Deferasirox | 12 | 20.6 | 20.6 |